source
- New acting head Karim Mikhail seeks to steady FDA’s biologics center after turbulent leadershipKarim Mikhail, the acting director of the FDA’s Center for Biologics Evaluation and Research, told staff in a town‑hall meeting that he understands the pressures they face and wants to work alongsi…
- Elevance Health to Exit Unsustainable Medicaid Markets Over Next 12-18 MonthsElevance Health, the nation's second-largest insurer, said on its Q2 earnings call it will further reduce its Medicaid business in the coming year. The move comes as several states are preparing t…